[Soft tissue tumors: indications and results of hyperthermia]. 1993

R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
Institut für klinische Hämatologie (GSF), Grosshadern.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D007069 Ifosfamide Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. Isofosfamide,Isophosphamide,Asta Z 4942,Holoxan,Iphosphamide,Iso-Endoxan,NSC-109,724,NSC-109724,Iso Endoxan,NSC 109,724,NSC 109724,NSC109,724,NSC109724
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
April 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
January 1983, Radiologia diagnostica,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
January 1987, Zentralblatt fur Chirurgie,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
August 1985, Der Radiologe,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
March 2011, Current treatment options in oncology,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
November 1977, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
April 1995, Nederlands tijdschrift voor geneeskunde,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
December 1989, The Journal of pathology,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
February 1990, Current opinion in rheumatology,
R D Issels, and D Bosse, and M Starck, and S Abdel-Rahman, and K W Jauch, and F W Schildberg, and W Wilmanns
October 1976, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!